Obesity and Sympathetic Overactivity in Young Individuals With Hypertension
Author Information
Author(s): Muacevic Alexander, Adler John R, Jadhav Uday, Solanki Dharmesh, Kumar Srinivas, Hazra Prakash, Alexander Thomas, Gupta Amit, Ghatge Shweta, Revankar Santosh
Primary Institution: Mahatma Gandhi Mission (MGM) New Bombay Hospital, Navi Mumbai
Hypothesis
What are the current clinical practices followed by healthcare professionals among populations with hypertension and obesity with sympathetic overactivity?
Conclusion
Sympathetic overactivity is becoming more common in young adults with hypertension, and the combination of telmisartan and cardio-selective beta-blockers is the best treatment option for these patients.
Supporting Evidence
- 53% of healthcare professionals believe that patients with hypertension and increased sympathetic overactivity are most commonly aged 41-60 years.
- 60% of patients with hypertension and sympathetic overactivity are at higher risk of developing stroke.
- 69% of healthcare professionals think that patients with hypertension and obesity are at greater risk of coronary artery disease.
Takeaway
Doctors think that young people with high blood pressure and weight problems often have a busy heart. They believe that a mix of two medicines can help them feel better.
Methodology
A standard questionnaire was used to gather information from healthcare professionals about their practices in managing young patients with hypertension and obesity.
Potential Biases
Self-reported data may lead to bias in the findings.
Limitations
The study relies on self-reported data from healthcare professionals, which may introduce bias.
Participant Demographics
Healthcare professionals from various regions of India participated in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website